These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 10812041

  • 1. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
    Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA.
    Biol Psychiatry; 2000 May 01; 47(9):818-29. PubMed ID: 10812041
    [Abstract] [Full Text] [Related]

  • 2. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N.
    Psychopharmacology (Berl); 2002 Jul 01; 162(3):323-32. PubMed ID: 12122491
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
    Dekeyne A, Gobert A, Auclair A, Girardon S, Millan MJ.
    Psychopharmacology (Berl); 2002 Jul 01; 162(2):156-67. PubMed ID: 12110993
    [Abstract] [Full Text] [Related]

  • 4. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons.
    Szabo ST, Blier P.
    Eur J Neurosci; 2001 Jun 01; 13(11):2077-87. PubMed ID: 11422448
    [Abstract] [Full Text] [Related]

  • 5. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
    Cryan JF, Page ME, Lucki I.
    Eur J Pharmacol; 2002 Feb 02; 436(3):197-205. PubMed ID: 11858799
    [Abstract] [Full Text] [Related]

  • 6. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
    Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH.
    CNS Drug Rev; 2004 Feb 02; 10(1):23-44. PubMed ID: 14978512
    [Abstract] [Full Text] [Related]

  • 7. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I.
    Psychopharmacology (Berl); 2007 Jun 02; 192(3):357-71. PubMed ID: 17318507
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
    Millan MJ, Dekeyne A.
    Int J Neuropsychopharmacol; 2007 Oct 02; 10(5):579-93. PubMed ID: 17076935
    [Abstract] [Full Text] [Related]

  • 9. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
    Andreasen JT, Redrobe JP.
    Behav Brain Res; 2009 Jan 30; 197(1):150-6. PubMed ID: 18786574
    [Abstract] [Full Text] [Related]

  • 10. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Dekeyne A, Papp M, La Rochelle CD, MacSweeny C, Peglion JL, Brocco M.
    J Pharmacol Exp Ther; 2001 Aug 30; 298(2):581-91. PubMed ID: 11454919
    [Abstract] [Full Text] [Related]

  • 11. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties.
    Artaiz I, Zazpe A, Innerárity A, Del Olmo E, Díaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A.
    Psychopharmacology (Berl); 2005 Nov 30; 182(3):400-13. PubMed ID: 16032410
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
    Page ME, Brown K, Lucki I.
    Psychopharmacology (Berl); 2003 Jan 30; 165(2):194-201. PubMed ID: 12426668
    [Abstract] [Full Text] [Related]

  • 13. Predicting response: noradrenaline reuptake inhibition.
    Montgomery SA.
    Int Clin Psychopharmacol; 1999 May 30; 14 Suppl 1():S21-6. PubMed ID: 10468325
    [Abstract] [Full Text] [Related]

  • 14. Selective noradrenaline reuptake inhibition enhances serotonergic neuronal activity and transmitter release in the rat forebrain.
    Linnér L, Wiker C, Arborelius L, Schalling M, Svensson TH.
    J Neural Transm (Vienna); 2004 Feb 30; 111(2):127-39. PubMed ID: 14767716
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of reboxetine in major depression.
    Schatzberg AF.
    J Clin Psychiatry; 2000 Feb 30; 61 Suppl 10():31-8. PubMed ID: 10910015
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.
    Ferris RM, Brieaddy L, Mehta N, Hollingsworth E, Rigdon G, Wang C, Soroko F, Wastila W, Cooper B.
    J Pharm Pharmacol; 1995 Sep 30; 47(9):775-81. PubMed ID: 8583392
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
    Dekeyne A, Gobert A, Iob L, Cistarelli L, Melon C, Millan MJ.
    Psychopharmacology (Berl); 2001 Nov 30; 158(2):213-8. PubMed ID: 11702096
    [Abstract] [Full Text] [Related]

  • 18. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL.
    J Pharmacol Exp Ther; 2001 Aug 30; 298(2):565-80. PubMed ID: 11454918
    [Abstract] [Full Text] [Related]

  • 19. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
    Bel N, Artigas F.
    J Pharmacol Exp Ther; 1996 Sep 30; 278(3):1064-72. PubMed ID: 8819487
    [Abstract] [Full Text] [Related]

  • 20. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.
    Rantamäki T, Hendolin P, Kankaanpää A, Mijatovic J, Piepponen P, Domenici E, Chao MV, Männistö PT, Castrén E.
    Neuropsychopharmacology; 2007 Oct 30; 32(10):2152-62. PubMed ID: 17314919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.